Literature DB >> 24880747

Ischemic stroke associated with immune thrombocytopenia: lesion patterns and characteristics.

Hong-Kyun Park1, Seung-Hoon Lee.   

Abstract

Although the patients with immune thrombocytopenia (ITP) have a very low platelet count, which usually causes hemorrhagic complications, they occasionally experience ischemic stroke. However, the mechanism underlying ITP-related ischemic stroke (ITP-IS) has not been fully clarified. We aim to elucidate the ITP-IS mechanism by analyzing the ischemic lesion patterns and clinical characteristics. We assessed consecutive first-ever acute ischemic stroke (AIS) patients with ITP admitted to Seoul National University Hospital between October 2002 and October 2011. The stroke lesion pattern and clinical characteristics of ITP-IS patients were analyzed. Of the 2,185 patients with first-ever AIS, seven patients (4 women) with ITP-IS were identified. Of these seven patients, 3 (43 %) who were classified as undetermined stroke etiology indicated an embolic stroke pattern, and had no remarkable atherosclerotic risk factors, no steno-occlusive lesions in their relevant artery, and no cardioembolic etiologies or conditions causing secondary ITP. Moreover, compared with the patients without ITP, the patients with ITP were younger and had lower platelet counts. Thus, we noted that ITP is a rare cause of ischemic stroke, which primarily occurs due to the development of a thromboembolism in the brain. We believe that this paradoxical mechanism of ITP-associated thrombus formation requires further investigation.

Entities:  

Mesh:

Year:  2014        PMID: 24880747     DOI: 10.1007/s10072-014-1843-0

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  10 in total

Review 1.  The ITP syndrome: pathogenic and clinical diversity.

Authors:  Douglas B Cines; James B Bussel; Howard A Liebman; Eline T Luning Prak
Journal:  Blood       Date:  2009-04-24       Impact factor: 22.113

2.  Contribution of diffusion-weighted imaging in determination of stroke etiology.

Authors:  T Wessels; C Wessels; A Ellsiepen; I Reuter; S Trittmacher; E Stolz; M Jauss
Journal:  AJNR Am J Neuroradiol       Date:  2006-01       Impact factor: 3.825

Review 3.  Review: intravenous immunoglobulin therapy and thromboembolic complications.

Authors:  U Katz; Y Shoenfeld
Journal:  Lupus       Date:  2005       Impact factor: 2.911

Review 4.  The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia.

Authors:  Cindy Neunert; Wendy Lim; Mark Crowther; Alan Cohen; Lawrence Solberg; Mark A Crowther
Journal:  Blood       Date:  2011-02-16       Impact factor: 22.113

5.  Paradoxical ischaemic stroke in the setting of idiopathic thrombocytopenic purpura.

Authors:  T G Phan; R Owen
Journal:  Intern Med J       Date:  2011-08       Impact factor: 2.048

6.  Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity.

Authors:  P J Sims; E M Faioni; T Wiedmer; S J Shattil
Journal:  J Biol Chem       Date:  1988-12-05       Impact factor: 5.157

7.  Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research Database.

Authors:  Ameet Sarpatwari; Dimitri Bennett; John W Logie; Amit Shukla; Kathleen J Beach; Adrian C Newland; Simon Sanderson; Drew Provan
Journal:  Haematologica       Date:  2010-02-09       Impact factor: 9.941

Review 8.  A patient with idiopathic thrombocytopenic purpura presenting with an acute ischemic stroke.

Authors:  Brett J Theeler; John P Ney
Journal:  J Stroke Cerebrovasc Dis       Date:  2008 Jul-Aug       Impact factor: 2.136

9.  High risk of severe bleeding in aged patients with chronic idiopathic thrombocytopenic purpura.

Authors:  S Cortelazzo; G Finazzi; M Buelli; A Molteni; P Viero; T Barbui
Journal:  Blood       Date:  1991-01-01       Impact factor: 22.113

10.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

  10 in total
  6 in total

1.  Ischemic stroke associated with immune thrombocytopenia.

Authors:  HongMei Zhao; YaJun Lian; HaiFeng Zhang; NanChang Xie; YanLun Gao; ZhongYue Wang; Yi Zhang
Journal:  J Thromb Thrombolysis       Date:  2015-08       Impact factor: 2.300

2.  Platelet count is associated with outcome in cancer patients with stroke.

Authors:  Bernardo Cacho-Díaz; Héctor Spínola-Maroño; Laura G Mendoza-Olivas; Myrna Candelaria
Journal:  J Neurooncol       Date:  2018-08-18       Impact factor: 4.130

3.  Multiple cerebral infarctions in a patient with idiopathic thrombocytopenic purpura.

Authors:  Masatoshi Yunoki; Kenta Suzuki; Atsuhito Uneda; Shuichi Okubo; Koji Hirashita; Kimihiro Yoshino
Journal:  Iran J Neurol       Date:  2016-07-06

4.  Vertebral Artery Thrombosis in Chronic Idiopathic Thrombocytopenic Purpura.

Authors:  Zakaria Hindi; Nirmal Onteddu; Christopher A Ching; Abdallah A Khaled
Journal:  Case Rep Hematol       Date:  2017-06-11

Review 5.  Pathogenesis of Two Faces of DVT: New Identity of Venous Thromboembolism as Combined Micro-Macrothrombosis via Unifying Mechanism Based on "Two-Path Unifying Theory" of Hemostasis and "Two-Activation Theory of the Endothelium".

Authors:  Jae C Chang
Journal:  Life (Basel)       Date:  2022-01-31

6.  Cancer Related Subarachnoid Hemorrhage: A Multicenter Retrospective Study Using Propensity Score Matching Analysis.

Authors:  Shijian Chen; Jian Zhang; Xianfu Lu; Gengyu Cen; Yiting Song; Xuhui Deng; Yiju Xie; Liuyu Liu; Qianqian Liu; Junling Huang; Jing Li; Hong Yang; Shengliang Shi; Liya Pan; Zhijian Liang
Journal:  Front Cell Neurosci       Date:  2022-02-07       Impact factor: 5.505

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.